Capital Growth
Compass Capital expands portfolio with over $110 million in new and increased stakes across diverse sectors.
Key Points
Boston Scientific: CEO Michael F. Mahoney purchased 186,240 shares on August 3, at an average cost of $48.33 per share, increasing his total stake to 1,590,024 shares valued at roughly $76.8 million, a 13.27% increase in their position.
Palo Alto Networks: Director James J. Goetz sold 20,000 shares on June 12 at an average price of $279.90, reducing his stake by 50% to 20,000 shares valued at about $5.6 million.
iShares Russell 2000 Growth ETF (IWO): Compass boosted its stake by 1,108.3% in Q2 to 13,811 shares valued at about $5.44 million, with institutional investors owning roughly 74.88% of IWO.
Roper Technologies (ROP): Compass acquired 142,079 shares in Q2, valued at about $48.08 million, making up about 2.9% of its portfolio and ranking as the fund’s 20th largest holding; analysts also noted price-target moves: JPMorgan raised its target to $415, while Piper Sandler lowered its target to $526.
Omnicom Group (OMC): Compass opened a new stake of 10,806 shares worth about $0.79 million; the article also highlights that hedge funds and institutional investors own a large portion of Omnicom stock (about 91.97%).
Compass Capital Management Inc. made roughly $110 million in new and expanded bets across five companies in the second quarter, according to Watchlist News and Ticker Report. The moves span medical devices, cybersecurity, industrials, small-cap growth ETFs, and marketing services — a broad push to reshape the fund's portfolio.
The firm's biggest single move was a $48.08 million purchase of Roper Technologies shares, making the industrial products company its 20th largest holding. A $36.7 million bet on Boston Scientific and a $25.07 million stake in Palo Alto Networks rounded out the headline moves.
Roper and Boston Scientific Lead the Big Bets
Compass bought 142,079 shares of Roper Technologies in Q2, valued at about $48.08 million. That block now makes up roughly 2.9% of the fund's total portfolio. Analysts are split on the stock's outlook — JPMorgan raised its price target to $415, while Piper Sandler cut its target to $526, according to Ticker Report.
The fund also grabbed 859,530 shares of Boston Scientific, worth about $36.7 million, placing the medical device maker at the fund's 25th largest holding. CEO Michael Mahoney separately bought 186,240 shares on August 3 at $48.33 each. That pushed his personal stake to 1,590,024 shares — a 13.27% increase — valued at roughly $76.8 million, per Watchlist News.
Palo Alto Networks Stake Opens as Director Sells Half His Shares
Compass opened a brand-new position in Palo Alto Networks, buying 73,515 shares for about $25.07 million. The cybersecurity firm is now the fund's 26th largest holding, according to Watchlist News.
The timing is notable. Director James Goetz sold 20,000 shares on June 12 at $279.90 each. That cut his personal stake by 50%, leaving him with 20,000 shares worth about $5.6 million. Compass was buying as an insider was cutting his position in half.
Small-Cap ETF Stake Jumps Over 1,100% in a Single Quarter
Compass massively expanded its position in the iShares Russell 2000 Growth ETF, known by its ticker IWO. The fund boosted its stake by 1,108.3%, ending Q2 with 13,811 shares worth about $5.44 million. The ETF tracks small, fast-growing U.S. companies. Institutional investors own roughly 74.88% of IWO, according to Ticker Report.
Omnicom and ServiceNow Round Out Portfolio Diversification Push
Compass opened a small new position in Omnicom Group — 10,806 shares worth about $787,000, per Ticker Report. Omnicom is a major marketing and advertising firm. Hedge funds and institutional investors already hold about 91.97% of the company's stock, making it a crowded but closely watched name.
The fund also bought 82,898 shares of ServiceNow worth $8.23 million in Q2, according to Watchlist News. Alongside the Royal Caribbean Cruises stake — 35,677 shares worth $11.33 million — Compass is clearly casting a wide net across sectors, from tech and healthcare to travel and advertising.
Sentiment
Mostly PositivePublishers
16
Articles
18
Reach
34
